PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals USA, Inc. an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the Food and Drug Administration (FDA) ...

AJOVY® now offers patients greater flexibility with two dosing options available in both an autoinjector and a prefilled syringe AJOVY® is the first and only subcutaneous anti-CGRP treatment with both ...

Teva Canada launches new Autoinjector for Ajovy to prevent migraine in adults AJOVY now offers patients greater flexibility with two dosing options available in both an autoinjector and a prefilled ...

AJOVY® now offers patients greater flexibility with two dosing options available in both an autoinjector and a prefilled syringe MONTRÉAL, April 8, 2021 /CNW/ - Teva Canada, a subsidiary of Teva ...

Health Canada approves Pr AJOVY® (fremanezumab solution for subcutaneous injection) for the prevention of episodic migraine (fewer than 15 migraine days per month) in pediatric patients aged 6 to 17 ...

If you have migraine, your doctor might suggest Ajovy (fremanezumab-vfrm) as a treatment option. Ajovy is a prescription medication that’s used to help prevent migraine headaches in adults. This ...

TORONTO, Feb. 4, 2026 /CNW/ - Teva Canada Limited (Teva Canada) announced today that Health Canada has approved an expanded indication for Pr AJOVY® (fremanezumab solution for subcutaneous injection) ...

Emgality (galcanezumab-gnlm) and Ajovy (fremanezumab-vfrm) are prescription drugs that help prevent migraine episodes. Both drugs come as a liquid solution that you inject under the skin. Emgality and ...